• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Wilmer Eye Institute awarded AHAF grants for glaucoma and AMD

Article

Glaucoma and age-related macular degeneration (AMD) research grants have been awarded to Wilmer Eye Institute by the American Health Assistance Foundation.

Baltimore-Three faculty members and a researcher at Wilmer Eye Institute at Johns Hopkins have received grants from the American Health Assistance Foundation (AHAF).

Wilmer faculty members Derek Welsbie, MD, PhD, assistant professor of ophthalmology; Shannath L. Merbs, MD, PhD, associate professor of ophthalmology and oncology and ophthalmic plastic and reconstructive surgery; and research associate Zhiyong Yang, MD, PhD, are investigating ways to promote the survival of retinal ganglion cells, the optic nerve cells normally damaged in glaucoma.

Noriko Esumi, MD, PhD, assistant professor of ophthalmology, is studying factors that control inflammation in age-related macular degeneration.

These were among 21 grants totaling $2.1 million recently awarded by the AHAF, which will support research projects in glaucoma and macular degeneration in the United States and abroad.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.